Sharma M, Molina CA, Toyoda K, Bereczki D, et al. Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol 2024;23:46-59.
PMID: 38101902